Botox Shows Promise for Dementia-Related Paratonia, Costs and Approvals Lag
Canadian researchers report that botulinum toxin injections can ease paratonia in advanced dementia, reducing pain and easing caregiving for more than 100 patients, but the treatment is not Health Canada-approved for paratonia and costs around $12,000 per year, limiting access and highlighting the need for larger trials.